Skip to content

osaühing MIECYS-PHARM

Registry code (registrikood) 10134440Private limited company (Osaühing)VAT EE100030475Activity (EMTAK 46461): Ravimite ja muude apteegikaupade hulgimüükActive

Saue vald, Harju County · Financial data: annual reports up to 2025; tax data up to 2026 Q3

Revenue (2025)
€2.0M
▼ 3.0% vs 2024
Profit before tax (2025)
€105k
Employees, FTE (2025)
3
State taxes paid, last 4 quarters
€390k

Revenue, profit and employees, 2019–2025

€2.8M2019€2.3M2020€1.6M2021€1.7M2022€2.1M2023€2.0M2024€2.0M2025
YearRevenue (müügitulu)Operating profit (ärikasum)Net profitEquity (omakapital)Employees, FTE
2019€2,775,460€63,858€53,062€806,4264
2020€2,268,551€4,427€4,443€809,5194
2021€1,563,317-€34,973-€34,953€647,0153
2022€1,742,641€47,130€47,148€694,1633
2023€2,054,671€127,252€130,122€824,2853
2024€2,048,523€64,567€67,900€892,1853
2025€1,986,418€103,653€104,658€996,8433

Balance sheet summary

YearCashTotal assetsCurrent liabilitiesNon-current liabilitiesEquity
2019€213,771€1,518,203€711,777—€806,426
2020€187,496€1,043,191€233,672—€809,519
2021€123,958€873,093€226,078—€647,015
2022€104,209€971,238€277,075—€694,163
2023€350,688€1,224,771€400,486—€824,285
2024€291,924€1,048,628€156,443—€892,185
2025€468,686€1,169,143€172,300—€996,843

Calculated ratios

Net profit margin = net profit ÷ revenue. Equity ratio = equity ÷ total assets. Seedata sources & methodology for how each figure is derived.

Quarterly tax and turnover data (EMTA)

QuarterState taxes paidWage taxesTurnoverEmployees
2022 Q1€71,848€19,960€644,1513
2022 Q2€78,727€20,359€785,8913
2022 Q3€74,781€19,244€732,5063
2022 Q4€81,547€19,468€602,6893
2023 Q1€123,868€43,387€828,3503
2023 Q2€74,057€16,237€663,5242
2023 Q3€62,683€13,484€573,5642
2023 Q4€111,154€15,738€1,253,8453
2024 Q1€102,649€21,385€981,0983
2024 Q2€76,124€20,080€786,0713
2024 Q3€66,397€17,832€566,7763
2024 Q4€103,795€17,629€900,1153
2025 Q1€95,312€21,002€894,2113
2025 Q2€87,749€18,753€675,9043
2025 Q3€77,893€18,388€678,7693
2025 Q4€104,689€19,985€1,007,5903
2026 Q1€113,557€25,110€897,0313
2026 Q2€80,999€19,971€644,4694
2026 Q3€91,164€21,106€679,6734

Source: EMTA quarterly published data, as of 10 October 2026. Covers state taxes and wage taxes actually paid and turnover and employee counts as declared by the company, not the annual report figures above.

About this data

In the 2025 financial year (period 1 January 2025–31 December 2025), osaühing MIECYS-PHARM reported revenue of €1,986,418.

The company closed the 2025 financial year with a net profit of €104,658.

Revenue decreased by 3.0% from €2,048,523 in 2024 to €1,986,418 in 2025.

Revenue grew at a compound annual rate of -5.4% between 2019 and 2025.

Equity accounted for 85.3% of total assets of €1,169,143 at the end of the 2025 reporting period.

With 3 full-time-equivalent employees in 2025, revenue per employee was €662,139.

Across the 4 most recent quarters declared to EMTA, up to Q3 2026, osaühing MIECYS-PHARM reported €3,228,763 in turnover.

EMTA recorded 4 employees for the quarter ending Q3 2026, compared with 3 full-time-equivalent employees in the 2025 annual report.

Browse

Source

Source: Estonian e-Business Register open data (Centre of Registers and Information Systems, RIK), licence CC BY-SA 4.0, modified; Estonian Tax and Customs Board (EMTA) quarterly data. Downloaded 2026-11-16. This is not an official register extract — see ariregister.rik.ee.

Company data on this site is available under CC BY-SA 4.0.

To request a correction or the removal of this page, use the contact form. Removal requests are handled within 30 days, no justification required.